IL124870A0 - Nitric oxide (no) synthase inhibitor to treat or prevent type ii diabetes - Google Patents
Nitric oxide (no) synthase inhibitor to treat or prevent type ii diabetesInfo
- Publication number
- IL124870A0 IL124870A0 IL12487096A IL12487096A IL124870A0 IL 124870 A0 IL124870 A0 IL 124870A0 IL 12487096 A IL12487096 A IL 12487096A IL 12487096 A IL12487096 A IL 12487096A IL 124870 A0 IL124870 A0 IL 124870A0
- Authority
- IL
- Israel
- Prior art keywords
- diabetes
- treat
- synthase inhibitor
- nitric oxide
- prevent type
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 title abstract 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 title 3
- 238000000034 method Methods 0.000 abstract 2
- 102000008299 Nitric Oxide Synthase Human genes 0.000 abstract 1
- 108010021487 Nitric Oxide Synthase Proteins 0.000 abstract 1
- HAMNKKUPIHEESI-UHFFFAOYSA-N aminoguanidine Chemical compound NNC(N)=N HAMNKKUPIHEESI-UHFFFAOYSA-N 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Steroid Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9526331.5A GB9526331D0 (en) | 1995-12-22 | 1995-12-22 | Novel method |
| PCT/EP1996/005871 WO1997023204A1 (en) | 1995-12-22 | 1996-12-18 | Nitric oxide (no) synthase inhibitor to treat or prevent type ii diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL124870A0 true IL124870A0 (en) | 1999-01-26 |
Family
ID=10785930
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12487096A IL124870A0 (en) | 1995-12-22 | 1996-12-18 | Nitric oxide (no) synthase inhibitor to treat or prevent type ii diabetes |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0868175B1 (hu) |
| JP (1) | JP2000502668A (hu) |
| KR (1) | KR19990076595A (hu) |
| CN (1) | CN1209057A (hu) |
| AT (1) | ATE232724T1 (hu) |
| AU (1) | AU1379497A (hu) |
| BR (1) | BR9612245A (hu) |
| CA (1) | CA2240396A1 (hu) |
| CZ (1) | CZ198698A3 (hu) |
| DE (1) | DE69626307T2 (hu) |
| ES (1) | ES2193285T3 (hu) |
| GB (1) | GB9526331D0 (hu) |
| HU (1) | HUP9903979A3 (hu) |
| IL (1) | IL124870A0 (hu) |
| MX (1) | MX9805098A (hu) |
| NO (1) | NO982854L (hu) |
| NZ (1) | NZ325307A (hu) |
| PL (1) | PL327472A1 (hu) |
| TR (1) | TR199801133T2 (hu) |
| WO (1) | WO1997023204A1 (hu) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999044598A2 (en) * | 1998-03-03 | 1999-09-10 | Board Of Regents, The University Of Texas System | Methods for inhibiting βcell apoptosis |
| CN1660428B (zh) * | 2005-01-10 | 2011-09-07 | 王振军 | 一氧化氮合酶（nos）抑制剂用于治疗痔的新用途 |
| ES2386831B1 (es) * | 2011-02-04 | 2013-07-08 | Servicio Andaluz De Salud | Uso de inhibidores de la actividad de las NO sintasas (NOS) y sus composiciones, en la elaboración de un medicamento para el tratamiento y la prevención de la prediabetes y la diabetes mellitus tipo 1 (DM1) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT793646E (pt) * | 1994-11-23 | 2002-03-28 | Biovitrum Ab | Carboxilatos de aminoguanidina destinados ao tratamento de diabetes mellitus nao-insulinodependente |
-
1995
- 1995-12-22 GB GBGB9526331.5A patent/GB9526331D0/en active Pending
-
1996
- 1996-12-18 ES ES96944077T patent/ES2193285T3/es not_active Expired - Lifetime
- 1996-12-18 BR BR9612245A patent/BR9612245A/pt not_active Application Discontinuation
- 1996-12-18 EP EP96944077A patent/EP0868175B1/en not_active Expired - Lifetime
- 1996-12-18 CN CN96199955A patent/CN1209057A/zh active Pending
- 1996-12-18 KR KR1019980704676A patent/KR19990076595A/ko not_active Application Discontinuation
- 1996-12-18 IL IL12487096A patent/IL124870A0/xx unknown
- 1996-12-18 WO PCT/EP1996/005871 patent/WO1997023204A1/en active IP Right Grant
- 1996-12-18 AU AU13794/97A patent/AU1379497A/en not_active Abandoned
- 1996-12-18 TR TR1998/01133T patent/TR199801133T2/xx unknown
- 1996-12-18 JP JP9523337A patent/JP2000502668A/ja not_active Ceased
- 1996-12-18 AT AT96944077T patent/ATE232724T1/de not_active IP Right Cessation
- 1996-12-18 CA CA002240396A patent/CA2240396A1/en not_active Abandoned
- 1996-12-18 PL PL96327472A patent/PL327472A1/xx unknown
- 1996-12-18 NZ NZ325307A patent/NZ325307A/en unknown
- 1996-12-18 CZ CZ981986A patent/CZ198698A3/cs unknown
- 1996-12-18 HU HU9903979A patent/HUP9903979A3/hu unknown
- 1996-12-18 DE DE69626307T patent/DE69626307T2/de not_active Expired - Fee Related
-
1998
- 1998-06-19 NO NO982854A patent/NO982854L/no not_active Application Discontinuation
- 1998-06-22 MX MX9805098A patent/MX9805098A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2193285T3 (es) | 2003-11-01 |
| ATE232724T1 (de) | 2003-03-15 |
| NO982854D0 (no) | 1998-06-19 |
| NZ325307A (en) | 1999-11-29 |
| HUP9903979A2 (hu) | 2000-03-28 |
| CA2240396A1 (en) | 1997-07-03 |
| PL327472A1 (en) | 1998-12-07 |
| KR19990076595A (ko) | 1999-10-15 |
| CN1209057A (zh) | 1999-02-24 |
| JP2000502668A (ja) | 2000-03-07 |
| NO982854L (no) | 1998-06-19 |
| CZ198698A3 (cs) | 1999-06-16 |
| TR199801133T2 (xx) | 1998-09-21 |
| MX9805098A (es) | 1998-10-31 |
| GB9526331D0 (en) | 1996-02-21 |
| WO1997023204A1 (en) | 1997-07-03 |
| HUP9903979A3 (en) | 2000-05-29 |
| DE69626307T2 (de) | 2003-10-16 |
| EP0868175B1 (en) | 2003-02-19 |
| EP0868175A1 (en) | 1998-10-07 |
| BR9612245A (pt) | 1999-07-13 |
| DE69626307D1 (de) | 2003-03-27 |
| AU1379497A (en) | 1997-07-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP9801272A0 (en) | Use of an antagonist of ppar-alpha and ppr-gamma for the treatment of syndrom X. | |
| EP0831832A4 (en) | METHODS FOR CONTROLLING INFECTIOUS DISEASES USING DICATIONIC BIS-BENZIMIDAZOLES | |
| MXPA02012763A (es) | Combinaciones de inhibidores de dipeptidil peptidasa iv y otros agentes antidiabeticos para el tratamiento de diabetes mellitus. | |
| AU3419995A (en) | Combination of an opioid antagonist and a selective serotonin reuptake inhibitor for treatment of alcoholism and alcohol dependence | |
| GB9317636D0 (en) | Use of dexmedetomidine | |
| GR3031917T3 (en) | Treatment of diseases caused by sebaceous gland disorders with acyl CoA cholesterol acyl transferase inhibitors | |
| WO2002005642A3 (en) | Synergistic biocidal compositions | |
| MX9707278A (es) | Derivados tipo mercapto y seleno como inhibidores de la oxido nitrico sintasa. | |
| ES2136581A1 (es) | Uso de derivados del acido-2-hidroxi-4-trifluorometilbenzoico para la preparacion de medicamentos utiles para inhibir el factor de transcripcion nuclear nf-kb. | |
| IL124870A0 (en) | Nitric oxide (no) synthase inhibitor to treat or prevent type ii diabetes | |
| AP9901720A0 (en) | Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitors. | |
| EP0974351A3 (en) | Medicament for preventing and treating gastrointestinal damage | |
| AU3581695A (en) | Method and means for prevention and treatment of secondary cataract | |
| AU7655494A (en) | Treatment of laminitis | |
| AU4937499A (en) | Use of succinic acid or salts thereof and method of treating insulin resistance | |
| MX9701606A (es) | Terapia de combinacion para evitar la perdida osea-progesterona y agonistas de estrogeno. | |
| WO1995005364A3 (en) | Inhibitors of biogenic amine transporters | |
| MY118982A (en) | Method of reducing tissue damage associated with ischemia | |
| IL124869A0 (en) | Aminoguanidine for treating niddm | |
| MX9604692A (es) | Derivados de quinoxalina para el tratamiento de tinnitus. | |
| AU5434899A (en) | Cancer treatment | |
| WO1998025594A3 (en) | Lamotrigine in the treatment and prophylaxis of migraine | |
| MD1296F1 (en) | The Nicolau method of treatment of the lichen planus | |
| ZA982808B (en) | Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of dementia | |
| EP0663211A4 (en) | AGENT FOR PREVENTION AND TREATMENT OF DIGESTIVE APPARATUS MUCOUS DISORDERS. |